WHO ICTRP trial

Mangosteen-derived Mangostin as a Topical Prophylaxis Against Catheter-related…

TCTR20250326007 · Thai Clinical Trials Registry (TCTR) · Not Recruiting

Key facts

Trial ID TCTR20250326007
Public title Mangosteen-derived Mangostin as a Topical Prophylaxis Against Catheter-related Infections: A Multicenter, Randomized Controlled Trial
Scientific title Mangosteen-derived Mangostin as a Topical Prophylaxis Against Catheter-related Infections: A Multicenter, Randomized Controlled Trial
Primary sponsor Phramongkutklao hospital
Registry Thai Clinical Trials Registry (TCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2
Countries Thailand
Conditions AKI, ESKD patients with new access of non tunneled hemodialysis catheter mangostin, non-tunneled hemodialysis catheter, exit site infection, catheter related blood stream infection;mangostin, non-tunneled hemodialysis catheter, exit site…
Interventions Mangostin ointment were applied identically to the catheter exit site immediately after insertion of the non-tunneled hemodialysis catheter and every session of hemodialysis. All patients were monitored until catheter removal, with…
Registration date Mar 26, 2025
Target size 62
Secondary IDs Nil Known
Registry page thaiclinicaltrials.org

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations